News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Mavacamten reduces blood flow obstruction in adolescents with HCM
14 Apr 2026
byStephen Padilla
Treatment with mavacamten, compared with placebo, results in significantly greater reduction in left ventricular outflow tract (LVOT) obstruction over 28 weeks among adolescent patients with obstructive hypertrophic cardiomyopathy (HCM), as shown in the SCOUT-HCM trial.








